MONOGENIC OBESITY
Clinical trials for MONOGENIC OBESITY explained in plain language.
Never miss a new study
Get alerted when new MONOGENIC OBESITY trials appear
Sign up with your email to follow new studies for MONOGENIC OBESITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for teens fighting genetic obesity with weekly injection
Disease control Recruiting nowThis study is observing how well a weekly injection called semaglutide helps teenagers with a rare genetic form of obesity lose weight and improve their health. About 70 teens aged 12-21 will receive the injection alongside diet and exercise advice for 68 weeks in a real-world cl…
Matched conditions: MONOGENIC OBESITY
Sponsor: Prof. Dr. Martin Wabitsch • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New drug trial targets root cause of rare, uncontrollable hunger
Disease control Recruiting nowThis study is testing an experimental drug called mibavademab for people with a rare, severe form of obesity caused by a specific genetic mutation that disrupts the body's ability to feel full. The main goal is to see if the drug can help control body weight and is safe to use. R…
Matched conditions: MONOGENIC OBESITY
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC